E-pharmacy and healthcare platform
| Date | Round | Amount |
|---|---|---|
| Oct 2021 | Series D Plus E-pharmacy PharmEasy raised about $350M in a pre-IPO round at a $5.6B valuation, with Amansa, OrbiMed, Steadview and ADQ. | $350M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.